Uplizna (inebilizumab)
pCPA File Number:
22632
Negotiation Status:
Active Negotiation
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Horizon Therapeutics Canada
CDA-AMC Project Number:
SR0793-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable